Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: Structure- activity relationship and mechanisms involved

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4610-4617

  Chung, Jee Y ^a   Huang, Chuanshu ^b   Meng, Xiaofeng ^a   Dong, Zigang ^b   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; POLYPHENOL DERIVATIVE; SYNAPTOPHYSIN; THEAFLAVIN; THEAFLAVINE 3 GALLATE; THEAFLAVINE 3' GALLATE; THEAFLAVINE DIGALLATE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; GROWTH INHIBITION; ISOMER; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKIN CANCER; STRUCTURE ACTIVITY RELATION; TEA;

EID: 0033568515     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Yang, C. S., and Wang, Z. Y. Tea and cancer. J. Natl. Cancer Inst., 85: 1038-1049, 1993.
2. Katiyar, S. K., and Mukhtar, H. Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int. J. Oncol., 8: 221-238, 1996.
3. Yang, G. Y., Wang, Z. Y., Kim, S., Liao, J., Seril, D. N., Chen, X., Smith, T. J., and Yang, C. S. Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. Cancer Res., 57: 1889-1894, 1997.
4. Huang, M. T., Xie, J. G., Wang, Z. Y., Ho, C. T., Lou, Y. R., Wang, C. X., Hard, G. C., and Conney, A. H. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as biologically important constituent of tea. Cancer Res., 57: 2623-2629, 1997.
5. Lu, Y. P., Lou, Y. R., Xie, J. G., Yen, P., Huang, M. T., and Conney, A. H. Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis, and bromodeoxyuridine incorporation into DNA. Carcinogenesis (Lond.), 18: 2163-2169, 1997.
6. Balentine, D. A., Wiseman, S. A., and Bouwens, L. C. M. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr., 37: 693-704, 1997.
7. Yang, C. S., Chen, L., Lee, M. J., and Landau, J. M. Effects of tea on carcinogenesis in animal models and humans (edited under the auspices of the American Institute for Cancer Research). In: Dietary Phytochemicals in Cancer Prevention and Treatment, pp. 51-61. New York: Plenum Press, 1996.
8. Yang, G. Y., Liao, J., Kim, K., Yurkow, E. J., and Yang, C. S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis (Lond), 19: 611-616, 1998.
9. Chen, Z. P., Schell, J. B., Ho, C. T., and Chen, K. Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett., 129: 173-179, 1998.
10. Nakayama, M., Suzuki, K., Toda, M., Okubo, S., Hara, Y., and Shimamura, T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antivir. Res., 21: 289-299, 1993.
11. Dong, Z. G., Ma, W. Y., Huang, C., and Yang, C. S Inhibition of tumor promoter-induced activator protein-1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Cancer Res., 57: 4414-4419, 1997.
12. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R. Soc. Lond. B Biol. Sci., 351: 127-134, 1996.
13. Karin, M., Liu, Z. G., and Zandi, E. AP-1 function and regulation. Curr Opin. Cell Biol., 9: 240-246, 1997.
14. Dong, Z. G., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA, 91: 609-613, 1994.
15. Dong, Z. G., Watts, R. G., Sun, Y., Zhan, S. N., and Colbum, N. H. Progressive elevation of AP-1 activity during preneoblastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Int. J. Oncol., 7: 359-364, 1995.
16. Huang, C. S., Ma, W. Y., Young, M. R., Colburn, N. H., and Dong, Z. G. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl. Acad. Sci. USA, 95: 156-161, 1998.
17. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
18. Huang, C. S., Ma, W. Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. G. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. USA, 94: 5826-5830, 1997.
19. Risse-Hackl, G., Adamkiewicz, J., Wimmel, A., and Schuermann, M. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene, 16: 3057-3068, 1998.
20. Dumont, J. A., Bitonti, A. J., Wallace, C. D., Baumann, R. J., Cashman, E. A., and Cross-Doersen, D. E. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ., 7: 351-359, 1996.
21. Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., and Spiegelman, B. M. c-Fos is required for malignant progression of skin tumors. Cell, 82: 721-732, 1995.
22. Dong, Z. G., Crawford, H. C., Lavrovsky, V., Taub, D., Watts, R., Matrisian, L. M., and Colburn, N. H. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinog., 19: 204-212, 1997.
23. Domann, F. E., Levy, J. P., Finch, J. S., and Bowden, G. T. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog., 9: 61-66, 1994.
24. Lamb, R. F., Hennigan, R. F., Turnbull, K., Katsanakis, K. D., MacKenzie, E. D., Birnie, G. D., and Ozanne, B. W. AP-1 mediated invasion requires increased expression of hyaluronan receptor CD44. Mol. Cell. Biol., 17: 963-976, 1997.
25. Crawford, H. C., and Matrisian, L. M. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein, 49: 20-37, 1996.
26. Wright, J. H., McDonnell, S., Portella, G., Bowden, G. T., Balmain, A., and Matrisian, L. M. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinog., 10: 207-215, 1994.
27. Zachos, G., and Spandidos, D. A. Expression of ras proto-oncogenes: regulation and implications in the development of human tumors. Crit. Rev. Oncol.-Hematol., 26: 65-75, 1997.
28. Laemmli, U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
29. Meyer, M., Pahl, H. L., and Baeuerle, P. A. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem-Biol. Interact., 91: 91-100, 1994.
30. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J., 12: 2005-2015, 1993.
31. Denhardt, D. T. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem. J., 318: 729-747, 1996.
32. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7: 2135-2148, 1993.
33. Mechta, F., Lallemand, D., Pfarr, C. M., and Yaniv, M. Transformation by ras modifies API composition and activity. Oncogene, 14: 837-847, 1997.
34. Okimoto, T., Kohno, K., Kuwano, M., Gopas, J., Kung, H-F., and Ono, M. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1. Oncogene, 12: 1625-1633, 1996.
35. Battista, S., Nigris, F., Fedele, M., Chiappetta, G., Scala, S., Vallone, D., Pierantoni, G. M., Megar, T., Santoro, M., Viglietto, G., Verde, P., and Fusco, A. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Oncogene, 17: 377-385, 1998.
36. Minden, A., Lin, A., Claret, F. X., Abo, A., and Karin, M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81: 1147-1157, 1995.
37. Barthelman, M., Bair, W. B., Stickland, K. K., Chen, W. X., Timmerman, N., Valcic, S., Dong, Z. G., and Bowden, G. T. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B induced AP-1 activity. Carcinogenesis (Lond.), 19: 2201-2204, 1998.
38. Mehansho, H., Butler, L. G., and Carlson, D. M. Dietary tannins and salivary proline-rich proteins: interaction, induction, and defense mechanisms. Annu. Rev. Nutr., 7: 423-440, 1987.
39. 1H-NMR spectroscopy. Eur. J. Biochem., 219: 923-935, 1994.
40. Charlton, A. J., Baxter, N. J., Lilley, T. H., Haslam, E., McDonald, C. J., and Williamson, M. P. Tannin interactions with a full-length human salivary proline-rich protein display a stronger affinity than with single proline-rich repeats. FEBS Lett., 382: 289-292, 1996.
41. Hanks, S. K., and Hunter T. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J., 9: 576-596, 1995.
42. Cohen, P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol., 7: 353-361, 1997.
43. Paul, A., Wilson, S., Belham, C. M., Robinson, C J. M., Scott, P. H., Gould, G. W., and Plevin, R. Stress-activated protein kinases: activation, regulation, and function. Cell. Signalling, 9: 403-410, 1997.
44. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
45. Knight, R. J., and Buxton, D. B. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem. Biophys. Res. Commun., 218: 83-88, 1996.
46. Bogoyevitch, M. A., Gillespie-Brown, J., Ketterman, A. J., Fuller, S. J., Ben-Levy, R., Ashworth, A., Marshall, C. J., and Sugden, P. H. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. P38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res., 79: 162-173, 1996.
47. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W., Strickler, J. E., McLaughlin, M. M., Siemens, I. R., Fisher, S. M., Livi, G. P., White, J. R., Adams, J. L., and Young. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (Lond.), 372: 739-746, 1994.
48. Beyaert, R., Cuenda, A., Berghe, W. V., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P., and Fiers, W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO J., 15: 1914-1923, 1996.
49. Bergers, G., Graninger, P., Braselmann, S., Wrighton, C., and Busslinger, M. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol., 15: 3748-3758, 1995.
50. 1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol., 72: 5015-5023, 1992.
51. Domann, F. E., Levy, J. P., Birrer, M. J., and Bowden, G. T. Stable expression of a c-jun deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ., 5: 9-16, 1994.